246,402 Shares in Ventas, Inc. $VTR Bought by Danske Bank A S

Danske Bank A S acquired a new position in Ventas, Inc. (NYSE:VTR) during the 2nd quarter, HoldingsChannel.com reports. The fund acquired 246,402 shares of the real estate investment trust’s stock, valued at approximately $21,880,000.

Other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. bought a new stake in shares of Ventas during the 2nd quarter worth $4,953,439,000. Capital World Investors bought a new position in Ventas during the fourth quarter valued at about $594,116,000. Norges Bank purchased a new stake in Ventas during the fourth quarter worth about $474,571,000. Deutsche Bank AG purchased a new stake in Ventas during the second quarter worth about $451,822,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Ventas by 32,509.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock worth $359,722,000 after acquiring an additional 4,634,520 shares during the period. Institutional investors own 94.18% of the company’s stock.

Insider Activity at Ventas

In related news, Director Michael J. Embler purchased 2,500 shares of Ventas stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.53% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research firms have weighed in on VTR. KeyCorp boosted their target price on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. UBS Group lifted their price target on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a report on Monday, May 4th. BMO Capital Markets upped their price objective on Ventas from $105.00 to $107.00 and gave the company an “outperform” rating in a research note on Tuesday, August 11th. Barclays started coverage on Ventas in a report on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price objective for the company. Finally, Evercore reissued an “outperform” rating and issued a $95.00 target price on shares of Ventas in a research report on Wednesday, April 29th. Fifteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Ventas presently has a consensus rating of “Moderate Buy” and an average target price of $98.00.

Ventas Stock Performance

NYSE VTR opened at $92.82 on Friday. The firm has a market cap of $47.61 billion, a P/E ratio of 171.89, a price-to-earnings-growth ratio of 2.12 and a beta of 0.69. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The company’s 50 day moving average is $91.18 and its 200-day moving average is $87.04. Ventas, Inc. has a 12-month low of $66.38 and a 12-month high of $101.60.

Ventas (NYSE:VTR) last released its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, topping the consensus estimate of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the firm earned $0.87 EPS. Ventas’s revenue for the quarter was up 21.7% on a year-over-year basis. Sell-side analysts predict that Ventas, Inc. will post 3.89 earnings per share for the current year.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.